Literature DB >> 23978948

Knee strength retention and analgesia with continuous perineural fentanyl infusion after total knee replacement: randomized controlled trial.

Devanand Mangar1, Rachel A Karlnoski, Collin J Sprenker, Katheryne L Downes, Narrene Taffe, Robert Wainwright, Kenneth Gustke, Thomas L Bernasek, Enrico Camporesi.   

Abstract

PURPOSE: Despite providing adequate pain relief, a femoral nerve block can induce postoperative muscle weakness after total knee arthoplasty (TKA). Fentanyl has been shown to have peripheral effects but has not been used as a perineural infusate alone after TKA.
METHODS: Sixty patients scheduled for TKA were randomized to one of three blinded groups: a continuous 24 h infusion of either fentanyl 3 μg/ml, ropivacaine 0.1%, or 0.9% normal saline through a femoral nerve sheath catheter at 10 ml/h. The main outcome was maximum voluntary isometric contraction (MVIC) in the quadriceps femoris (knee extension), measured by a handheld dynamometer (Nm/kg). Other variables assessed were preoperative and postoperative visual analog scale (VAS) scores, hamstrings MVIC (knee flexion), active range of motion of the operative knee, distance ambulated, incidence of knee buckling, supplemental morphine usage, postoperative side effects, and serum fentanyl levels.
RESULTS: Quadriceps MVIC values were significantly greater in the fentanyl group compared to the group that received ropivacaine (median values, 0.08 vs. 0.03 Nm/kg; p = 0.028). The incidence of postoperative knee buckling upon ambulation was higher in the ropivacaine group compared to the fentanyl group, although not statistically significant (40% vs. 15 %, respectively; p = 0.077). VAS scores while ambulating were not significantly different between the fentanyl group and the ropivacaine group (p = 0.270). Postoperative morphine consumption, nausea and vomiting, and resting VAS scores were similar among the three groups.
CONCLUSIONS: A continuous perineural infusion of fentanyl produced greater strength retention than ropivacaine post-TKA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23978948     DOI: 10.1007/s00540-013-1700-y

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  28 in total

1.  Combined sciatic-femoral nerve block with 0.75% ropivacaine: effects of adding a systemically inactive dose of fentanyl.

Authors:  L Magistris; A Casati; A Albertin; F Deni; G Danelli; B Borghi; G Fanelli
Journal:  Eur J Anaesthesiol       Date:  2000-06       Impact factor: 4.330

2.  The end of postoperative pain--a fast-approaching possibility? And, if so, will we be ready?

Authors:  Brian M Ilfeld; Tony L Yaksh
Journal:  Reg Anesth Pain Med       Date:  2009 Mar-Apr       Impact factor: 6.288

3.  Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis.

Authors:  Jeffrey M Richman; Spencer S Liu; Genevieve Courpas; Robert Wong; Andrew J Rowlingson; John McGready; Seth R Cohen; Christopher L Wu
Journal:  Anesth Analg       Date:  2006-01       Impact factor: 5.108

4.  Fentanyl does not improve the nerve block characteristics of axillary brachial plexus anaesthesia performed with ropivacaine.

Authors:  G Fanelli; A Casati; L Magistris; M Berti; A Albertin; M Scarioni; G Torri
Journal:  Acta Anaesthesiol Scand       Date:  2001-05       Impact factor: 2.105

5.  Is hand-held dynamometry useful for the measurement of quadriceps strength in older people? A comparison with the gold standard Bodex dynamometry.

Authors:  H J Martin; V Yule; H E Syddall; E M Dennison; C Cooper; A Aihie Sayer
Journal:  Gerontology       Date:  2006       Impact factor: 5.140

Review 6.  Peripheral mechanisms of opioid analgesia.

Authors:  C Stein
Journal:  Anesth Analg       Date:  1993-01       Impact factor: 5.108

7.  Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial μ-opioid receptor agonist buprenorphine.

Authors:  Andreas Leffler; Georg Frank; Katrin Kistner; Florian Niedermirtl; Wolfgang Koppert; Peter W Reeh; Carla Nau
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

8.  Novel analgesic adjuncts for brachial plexus block: a systematic review.

Authors:  D B Murphy; C J McCartney; V W Chan
Journal:  Anesth Analg       Date:  2000-05       Impact factor: 5.108

9.  Continuous femoral nerve blocks: varying local anesthetic delivery method (bolus versus basal) to minimize quadriceps motor block while maintaining sensory block.

Authors:  Matthew T Charous; Sarah J Madison; Preetham J Suresh; NavParkash S Sandhu; Vanessa J Loland; Edward R Mariano; Michael C Donohue; Pascual H Dutton; Eliza J Ferguson; Brian M Ilfeld
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

Review 10.  Peripheral mechanisms of opioid analgesia.

Authors:  Christoph Stein; Leonie Julia Lang
Journal:  Curr Opin Pharmacol       Date:  2009-01-20       Impact factor: 5.547

View more
  4 in total

1.  Nalbuphine as an adjuvant to 0.25% levobupivacaine in ultrasound-guided supraclavicular block provided prolonged sensory block and similar motor block durations (RCT).

Authors:  Bassant Mohamed Abdelhamid; Heba Omar
Journal:  J Anesth       Date:  2018-05-28       Impact factor: 2.078

2.  Femoral nerve block for patient undergoing total knee arthroplasty: Prospective, randomized, double-blinded study evaluating analgesic effect of perineural fentanyl additive to local anesthetics.

Authors:  Bong Ha Heo; Hyeon Jung Lee; Hyung Gon Lee; Man Young Kim; Keun Suk Park; Jeong Il Choi; Myung Ha Yoon; Woong Mo Kim
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

3.  Was femoral nerve block effective for pain control of medial opening-wedge high tibial osteotomy?: A single blinded randomized controlled study.

Authors:  Yi-Ming Ren; Meng-Qiang Tian; Yuan-Hui Duan; Yun-Bo Sun; Tao Yang; Wei-Yu Hou; Shu-Hua Xie
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

4.  Controlled Hypotension Combined with Femoral Nerve Block for Knee Replacement without Tourniquet.

Authors:  Liangming Wang; Yiqiang Zheng; Xiaolu Zhang; Qingfeng Ke
Journal:  J Healthc Eng       Date:  2021-12-09       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.